Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post‐Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
Year: 2024
Type: article
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.31489
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405654952
